Employees Retirement System of Texas Makes New $52.20 Million Investment in GE HealthCare Technologies Inc. $GEHC

Employees Retirement System of Texas bought a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 695,000 shares of the company’s stock, valued at approximately $52,195,000.

Several other institutional investors also recently modified their holdings of GEHC. Vanguard Group Inc. lifted its holdings in GE HealthCare Technologies by 1.4% during the second quarter. Vanguard Group Inc. now owns 52,107,758 shares of the company’s stock worth $3,859,622,000 after acquiring an additional 703,903 shares during the period. Capital Research Global Investors grew its stake in GE HealthCare Technologies by 25.0% in the 3rd quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock valued at $1,875,400,000 after purchasing an additional 4,998,154 shares during the period. Dodge & Cox increased its position in shares of GE HealthCare Technologies by 42.1% during the 2nd quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock valued at $1,745,678,000 after purchasing an additional 6,982,441 shares during the last quarter. State Street Corp increased its position in shares of GE HealthCare Technologies by 1.9% during the 2nd quarter. State Street Corp now owns 19,660,742 shares of the company’s stock valued at $1,456,271,000 after purchasing an additional 372,755 shares during the last quarter. Finally, Geode Capital Management LLC raised its stake in shares of GE HealthCare Technologies by 2.0% during the 2nd quarter. Geode Capital Management LLC now owns 11,944,407 shares of the company’s stock worth $881,060,000 after purchasing an additional 231,302 shares during the period. 82.06% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on GEHC shares. BTIG Research boosted their price target on shares of GE HealthCare Technologies from $87.00 to $91.00 and gave the stock a “buy” rating in a report on Wednesday, February 4th. Wall Street Zen raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, March 7th. Citigroup dropped their target price on shares of GE HealthCare Technologies from $88.00 to $84.00 and set a “neutral” rating on the stock in a research note on Wednesday. The Goldman Sachs Group reissued a “buy” rating and set a $98.00 target price on shares of GE HealthCare Technologies in a research report on Friday, January 9th. Finally, UBS Group lowered shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and raised their price target for the stock from $73.00 to $77.00 in a research note on Thursday, January 15th. Seven investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $92.17.

GE HealthCare Technologies Trading Down 3.2%

Shares of GEHC opened at $70.33 on Friday. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $89.77. The business has a 50-day moving average of $81.02 and a 200 day moving average of $78.51. The firm has a market cap of $32.05 billion, a P/E ratio of 15.42, a price-to-earnings-growth ratio of 1.60 and a beta of 1.03. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, beating the consensus estimate of $1.40 by $0.04. The business had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The company’s revenue was up 7.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be paid a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio is presently 3.07%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.